Objective Lupus nephritis (LN) is a prevalent renal manifestation in patients with SLE, with kidney biopsy remaining the gold ...
Background Increasing reports of life-threatening complications in young children exposed to skin-lightening products present a significant public health concern, yet this issue remains ...
(RTTNews) - Exact Sciences Corp. (EXAS), Friday announced the landmark clinical results from its ALTUS study, showing that the Oncoguard Liver blood test significantly outperforms ultrasound in ...
Abbott Laboratories is nearing a potential acquisition of cancer screening company Exact Sciences Corp., people familiar with the matter said, in what could be the biggest deal of the year in the ...
Investors are flocking to bonds issued by (almost all) of the Magnificent Seven companies, drawn in by some of the juiciest yields seen on such high-quality names. Select Magnificent Seven 10-year ...
Exact Sciences Corporation stock surged after Abbott Laboratories announces a $21bn acquisition at $105 per share. Click here to find out why ABT is a Hold.
Exact Sciences’ third quarter results received a positive response from the market, reflecting strong revenue growth and robust execution in its core screening business. Management attributed the ...
President Donald Trump keeps touting the fact that Walmart’s promotional Thanksgiving meal basket is cheaper this year than it was last year. But Trump hasn’t mentioned that this year’s basket is ...
Hosted on MSN
Madison's Exact Sciences' $23 billion sale is tied to its Cologuard cancer test. What to know
The pending $23 billion sale of Madison-based Exact Sciences to health care giant Abbott centers on Exact Sciences' flagship product: colorectal cancer test Cologuard. Exact Sciences markets Cologuard ...
Fantasy TV is always fun, providing viewers with an escape to a magical world that is often so much more interesting than that of our own. But a lot of these shows can run for quite a long time, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results